chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: all the typical side effects for the vaccine but they lasted for a month; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of VACCINATION COMPLICATION (all the typical side effects for the vaccine but they lasted for a month) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (all the typical side effects for the vaccine but they lasted for a month). At the time of the report, VACCINATION COMPLICATION (all the typical side effects for the vaccine but they lasted for a month) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Muscle tightness, Pain in extremity, Pruritus, Rash erythematous
Clinical narrative: Little red bumps; Tightness in the muscle; Zone of 2x2 inches of redness and little Red bumps underneath the injection site; Redness; Red little bumps were itching; Hives next to the injection site; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives next to the injection site), PAIN IN EXTREMITY (Sore arm), ERYTHEMA (Redness), RASH ERYTHEMATOUS (Little red bumps) and PRURITUS (Red little bumps were itching) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Sulfas and Bactrim).    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 02-Mar-2021, the patient experienced URTICARIA (Hives next to the injection site), ERYTHEMA (Redness) and PRURITUS (Red little bumps were itching). On 06-Mar-2021, the patient experienced RASH ERYTHEMATOUS (Little red bumps), MUSCLE TIGHTNESS (Tightness in the muscle) and VACCINATION SITE ERYTHEMA (Zone of 2x2 inches of redness and little Red bumps underneath the injection site). On 27-Feb-2021, PAIN IN EXTREMITY (Sore arm) outcome was unknown. At the time of the report, URTICARIA (Hives next to the injection site), ERYTHEMA (Redness), RASH ERYTHEMATOUS (Little red bumps), PRURITUS (Red little bumps were itching), MUSCLE TIGHTNESS (Tightness in the muscle) and VACCINATION SITE ERYTHEMA (Zone of 2x2 inches of redness and little Red bumps underneath the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment includes cool compress and some cream. No relevant concomitant medications were reported.   This case was linked to MOD-2021-101717 (Patient Link).
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria, Vaccination site erythema
Clinical narrative: Little red bumps; Tightness in the muscle; Zone of 2x2 inches of redness and little Red bumps underneath the injection site; Redness; Red little bumps were itching; Hives next to the injection site; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives next to the injection site), PAIN IN EXTREMITY (Sore arm), ERYTHEMA (Redness), RASH ERYTHEMATOUS (Little red bumps) and PRURITUS (Red little bumps were itching) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Sulfas and Bactrim).    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 02-Mar-2021, the patient experienced URTICARIA (Hives next to the injection site), ERYTHEMA (Redness) and PRURITUS (Red little bumps were itching). On 06-Mar-2021, the patient experienced RASH ERYTHEMATOUS (Little red bumps), MUSCLE TIGHTNESS (Tightness in the muscle) and VACCINATION SITE ERYTHEMA (Zone of 2x2 inches of redness and little Red bumps underneath the injection site). On 27-Feb-2021, PAIN IN EXTREMITY (Sore arm) outcome was unknown. At the time of the report, URTICARIA (Hives next to the injection site), ERYTHEMA (Redness), RASH ERYTHEMATOUS (Little red bumps), PRURITUS (Red little bumps were itching), MUSCLE TIGHTNESS (Tightness in the muscle) and VACCINATION SITE ERYTHEMA (Zone of 2x2 inches of redness and little Red bumps underneath the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment includes cool compress and some cream. No relevant concomitant medications were reported.   This case was linked to MOD-2021-101717 (Patient Link).
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pyrexia
Clinical narrative: Tiredness; Fever with head ache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tiredness), PYREXIA (Fever) and HEADACHE (Fever with head ache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032m20a and 012m20a) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced PYREXIA (Fever). On 08-Mar-2021, the patient experienced FATIGUE (Tiredness) and HEADACHE (Fever with head ache). On 06-Mar-2021, PYREXIA (Fever) had resolved. At the time of the report, FATIGUE (Tiredness) and HEADACHE (Fever with head ache) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Vaccination site swelling
Clinical narrative: Site of injection is swelling; Swelling of lymph nodes in both arms; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Site of injection is swelling) and LYMPHADENOPATHY (Swelling of lymph nodes in both arms) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Site of injection is swelling) and LYMPHADENOPATHY (Swelling of lymph nodes in both arms). At the time of the report, VACCINATION SITE SWELLING (Site of injection is swelling) and LYMPHADENOPATHY (Swelling of lymph nodes in both arms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Discomfort, Dyspnoea, Hyperhidrosis
Clinical narrative: Really really sick after receiving the vaccine; Got all the side effects except the rash; Felt horrible; Sweating; Difficulty breathing; Feeling weak; Felt freezing cold; Fever; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Really really sick after receiving the vaccine), VACCINATION COMPLICATION (Got all the side effects except the rash), DISCOMFORT (Felt horrible), HYPERHIDROSIS (Sweating) and DYSPNOEA (Difficulty breathing) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure management.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced MALAISE (Really really sick after receiving the vaccine), VACCINATION COMPLICATION (Got all the side effects except the rash), DISCOMFORT (Felt horrible), HYPERHIDROSIS (Sweating), DYSPNOEA (Difficulty breathing), ASTHENIA (Feeling weak), CHILLS (Felt freezing cold), PYREXIA (Fever) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at a dose of 1 dosage form. On 07-Mar-2021, MALAISE (Really really sick after receiving the vaccine), VACCINATION COMPLICATION (Got all the side effects except the rash), DISCOMFORT (Felt horrible), HYPERHIDROSIS (Sweating), DYSPNOEA (Difficulty breathing), CHILLS (Felt freezing cold), PYREXIA (Fever) and NAUSEA (Nausea) had resolved. On 08-Mar-2021, ASTHENIA (Feeling weak) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications include Blood pressure medications
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Nausea, Pyrexia, Vaccination complication
Clinical narrative: Really really sick after receiving the vaccine; Got all the side effects except the rash; Felt horrible; Sweating; Difficulty breathing; Feeling weak; Felt freezing cold; Fever; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Really really sick after receiving the vaccine), VACCINATION COMPLICATION (Got all the side effects except the rash), DISCOMFORT (Felt horrible), HYPERHIDROSIS (Sweating) and DYSPNOEA (Difficulty breathing) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure management.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced MALAISE (Really really sick after receiving the vaccine), VACCINATION COMPLICATION (Got all the side effects except the rash), DISCOMFORT (Felt horrible), HYPERHIDROSIS (Sweating), DYSPNOEA (Difficulty breathing), ASTHENIA (Feeling weak), CHILLS (Felt freezing cold), PYREXIA (Fever) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at a dose of 1 dosage form. On 07-Mar-2021, MALAISE (Really really sick after receiving the vaccine), VACCINATION COMPLICATION (Got all the side effects except the rash), DISCOMFORT (Felt horrible), HYPERHIDROSIS (Sweating), DYSPNOEA (Difficulty breathing), CHILLS (Felt freezing cold), PYREXIA (Fever) and NAUSEA (Nausea) had resolved. On 08-Mar-2021, ASTHENIA (Feeling weak) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications include Blood pressure medications
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Dry mouth, Skin exfoliation, Tongue discomfort
Clinical narrative: burning tongue, like she ate spice food; mouth dry, like she ate metal; peeling subsided is little better; This spontaneous case was reported by a consumer and describes the occurrence of TONGUE DISCOMFORT (burning tongue, like she ate spice food), DRY MOUTH (mouth dry, like she ate metal) and SKIN EXFOLIATION (peeling subsided is little better) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 011L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was reported.). Concomitant products included AMLODIPINE for an unknown indication.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced TONGUE DISCOMFORT (burning tongue, like she ate spice food), DRY MOUTH (mouth dry, like she ate metal) and SKIN EXFOLIATION (peeling subsided is little better). At the time of the report, TONGUE DISCOMFORT (burning tongue, like she ate spice food), DRY MOUTH (mouth dry, like she ate metal) and SKIN EXFOLIATION (peeling subsided is little better) outcome was unknown.            No treatment information was provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Agitation, Anxiety, Chest discomfort, Confusional state
Clinical narrative: Chest tightest; She felt agitation; She felt spacey; Had anxiety; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHEST DISCOMFORT (Chest tightest), CONFUSIONAL STATE (She felt spacey), ANXIETY (Had anxiety) and AGITATION (She felt agitation) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced CONFUSIONAL STATE (She felt spacey) and ANXIETY (Had anxiety). On 04-Feb-2021, the patient experienced AGITATION (She felt agitation). On 14-Feb-2021, the patient experienced CHEST DISCOMFORT (Chest tightest). On 20-Feb-2021, CONFUSIONAL STATE (She felt spacey), ANXIETY (Had anxiety) and AGITATION (She felt agitation) had resolved. At the time of the report, CHEST DISCOMFORT (Chest tightest) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Ear pain, Pyrexia, Vaccination site induration, Vaccination site swelling
Clinical narrative: pain and pressure in the left ear; right arm swelling; chills; fever; hard area at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (right arm swelling), CHILLS (chills), PYREXIA (fever), VACCINATION SITE INDURATION (hard area at injection site) and EAR PAIN (pain and pressure in the left ear) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included VITAMINS NOS.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 28-Feb-2021, the patient experienced VACCINATION SITE SWELLING (right arm swelling), CHILLS (chills), PYREXIA (fever) and VACCINATION SITE INDURATION (hard area at injection site). On 08-Mar-2021, the patient experienced EAR PAIN (pain and pressure in the left ear). At the time of the report, VACCINATION SITE SWELLING (right arm swelling), CHILLS (chills), PYREXIA (fever), VACCINATION SITE INDURATION (hard area at injection site) and EAR PAIN (pain and pressure in the left ear) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication taken Nyquil.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pruritus
Clinical narrative: sore arm; Itchiness at the site injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and VACCINATION SITE PRURITUS (Itchiness at the site injection) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and VACCINATION SITE PRURITUS (Itchiness at the site injection). At the time of the report, PAIN IN EXTREMITY (sore arm) and VACCINATION SITE PRURITUS (Itchiness at the site injection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included Advil.   Reporter did not allow further contact
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Loss of personal independence in daily activities
Clinical narrative: weak; fatigued; unable to get out of bed; unable to care for themself; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of FATIGUE (weak), FATIGUE (fatigued), ASTHENIA (unable to get out of bed) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (unable to care for themself) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced FATIGUE (weak), FATIGUE (fatigued), ASTHENIA (unable to get out of bed) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (unable to care for themself). At the time of the report, FATIGUE (weak), FATIGUE (fatigued), ASTHENIA (unable to get out of bed) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (unable to care for themself) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No Concomitant medications were provided. No Treatment history was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-037341 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-037341:
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Erythema, Gait disturbance, Pyrexia
Clinical narrative: Chills; Fever; Swollen; red; Can't walk nor stand; No strength on the legs; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Can't walk nor stand), ASTHENIA (No strength on the legs), CHILLS (Chills), PYREXIA (Fever) and SWELLING (Swollen) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Glaucoma. Concomitant products included SIMVASTATIN, METFORMIN, ALUMINIUM HYDROXIDE GEL, DRIED, MAGNESIUM CARBONATE (PEPCID [ALUMINIUM HYDROXIDE GEL, DRIED;MAGNESIUM CARBONATE]), OMEPRAZOLE, LEVOTHYROXINE SODIUM (SYNTHYROID), BISOPROLOL, BUSPIRONE, DENOSUMAB (PROLIA), VITAMINS NOS and ZINC for an unknown indication, LIPO FLAVONOID PLUS.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced GAIT DISTURBANCE (Can't walk nor stand) and ASTHENIA (No strength on the legs). On an unknown date, the patient experienced CHILLS (Chills), PYREXIA (Fever), SWELLING (Swollen) and ERYTHEMA (red). At the time of the report, GAIT DISTURBANCE (Can't walk nor stand), ASTHENIA (No strength on the legs), CHILLS (Chills), PYREXIA (Fever), SWELLING (Swollen) and ERYTHEMA (red) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications were not provided by reporter.   Reporter did not allow further contact; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling
Clinical narrative: Chills; Fever; Swollen; red; Can't walk nor stand; No strength on the legs; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Can't walk nor stand), ASTHENIA (No strength on the legs), CHILLS (Chills), PYREXIA (Fever) and SWELLING (Swollen) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Glaucoma. Concomitant products included SIMVASTATIN, METFORMIN, ALUMINIUM HYDROXIDE GEL, DRIED, MAGNESIUM CARBONATE (PEPCID [ALUMINIUM HYDROXIDE GEL, DRIED;MAGNESIUM CARBONATE]), OMEPRAZOLE, LEVOTHYROXINE SODIUM (SYNTHYROID), BISOPROLOL, BUSPIRONE, DENOSUMAB (PROLIA), VITAMINS NOS and ZINC for an unknown indication, LIPO FLAVONOID PLUS.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced GAIT DISTURBANCE (Can't walk nor stand) and ASTHENIA (No strength on the legs). On an unknown date, the patient experienced CHILLS (Chills), PYREXIA (Fever), SWELLING (Swollen) and ERYTHEMA (red). At the time of the report, GAIT DISTURBANCE (Can't walk nor stand), ASTHENIA (No strength on the legs), CHILLS (Chills), PYREXIA (Fever), SWELLING (Swollen) and ERYTHEMA (red) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications were not provided by reporter.   Reporter did not allow further contact; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental underdose, Vaccination site erythema
Clinical narrative: very little red spot at the site of the injection , smaller than a bite of an insect ¨; received a lower dose than the recommended; A spontaneous report was received from a consumer concerning a 66-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events received a lower dose than the recommended, very little red spot at the site of the injection , smaller than a bite of an insect â¨, a friend knows people who works in another pharmacy next to the one she got the vaccine , was.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 3 Mar 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 029A21A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 3 Mar 2021, the patient experienced the event(s) received a lower dose than the recommended . On 8 Mar 2021, the patient experienced the event(s) very little red spot at the site of the injection . smaller than a bite of an insect â¨. On an unknown date, the patient experienced the event(s) A friend knows people who works in another pharmacy next to the one she got the vaccine . was.  Treatment details included No.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), received a lower dose than the recommended, very little red spot at the site of the injection ,smaller than a bite of an insect â¨,a friend knows people who works in another pharmacy next to the one she got the vaccine ,was was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: patient might have received saline instead of vaccine; This spontaneous case was reported by a consumer and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (patient might have received saline instead of vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no reported medical history).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (patient might have received saline instead of vaccine). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (patient might have received saline instead of vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant information not provided. Treatment information not provided
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: Itchy; Rash on the site of the vaccination and about 7 inches long and 4 or 5 inches wide, very irregular; Swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE RASH (Rash on the site of the vaccination and about 7 inches long and 4 or 5 inches wide, very irregular) and VACCINATION SITE SWELLING (Swollen) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy. Concomitant products included LEVOTHYROXINE for Thyroid disorder, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE RASH (Rash on the site of the vaccination and about 7 inches long and 4 or 5 inches wide, very irregular) and VACCINATION SITE SWELLING (Swollen). At the time of the report, VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE RASH (Rash on the site of the vaccination and about 7 inches long and 4 or 5 inches wide, very irregular) and VACCINATION SITE SWELLING (Swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment related information has been reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-101746 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Patient's contact details, action taken, Product-Event details tab with action taken, Dechallenge and rechallenge was updated. Extra Events with same PT was deleted and were merged together into single event (Vaccination Site Rash) and Patient's Date of birth was added.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-101746:2nd dose
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Swelling, Vaccination site haemorrhage, Vaccination site pruritus
Clinical narrative: There is blood underneath area above on the shoulder from the injection site; It is itchy in area above on the shoulder from the injection site; One week after receiving 1st dose, patient noticed swelling above on the shoulder from the injection site; Redness above on the shoulder from the injection site; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (One week after receiving 1st dose, patient noticed swelling above on the shoulder from the injection site), ERYTHEMA (Redness above on the shoulder from the injection site), VACCINATION SITE HAEMORRHAGE (There is blood underneath area above on the shoulder from the injection site) and VACCINATION SITE PRURITUS (It is itchy in area above on the shoulder from the injection site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     Concomitant products included GABAPENTIN, CALCIUM, CYANOCOBALAMIN (VITAMIN B-12), POTASSIUM, BISOPROLOL, Thyroid medication and SIMVASTATIN for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced SWELLING (One week after receiving 1st dose, patient noticed swelling above on the shoulder from the injection site), ERYTHEMA (Redness above on the shoulder from the injection site) and VACCINATION SITE PRURITUS (It is itchy in area above on the shoulder from the injection site). On an unknown date, the patient experienced VACCINATION SITE HAEMORRHAGE (There is blood underneath area above on the shoulder from the injection site). At the time of the report, SWELLING (One week after receiving 1st dose, patient noticed swelling above on the shoulder from the injection site), ERYTHEMA (Redness above on the shoulder from the injection site), VACCINATION SITE HAEMORRHAGE (There is blood underneath area above on the shoulder from the injection site) and VACCINATION SITE PRURITUS (It is itchy in area above on the shoulder from the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Groin pain, Headache, Pain in extremity, Tenderness
Clinical narrative: tenderness in my lymph nodes in my arm/left groin I feel some tenderness; soreness in my arm; left groin I feel some pain; headache; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (tenderness in my lymph nodes in my arm/left groin I feel some tenderness), PAIN IN EXTREMITY (soreness in my arm), GROIN PAIN (left groin I feel some pain) and HEADACHE (headache) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concomitant products included EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE (TRUVADA) for an unknown indication.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced HEADACHE (headache). On 07-Mar-2021, the patient experienced TENDERNESS (tenderness in my lymph nodes in my arm/left groin I feel some tenderness), PAIN IN EXTREMITY (soreness in my arm) and GROIN PAIN (left groin I feel some pain). At the time of the report, TENDERNESS (tenderness in my lymph nodes in my arm/left groin I feel some tenderness), PAIN IN EXTREMITY (soreness in my arm), GROIN PAIN (left groin I feel some pain) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Product storage error, Product use issue
Clinical narrative: mobilized and gave ALL 100 vaccines; excursion; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT STORAGE ERROR (excursion) and PRODUCT USE ISSUE (mobilized and gave ALL 100 vaccines) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced PRODUCT STORAGE ERROR (excursion). On 08-Jan-2021, the patient experienced PRODUCT USE ISSUE (mobilized and gave ALL 100 vaccines). On 07-Jan-2021, PRODUCT STORAGE ERROR (excursion) outcome was unknown. On 08-Jan-2021, PRODUCT USE ISSUE (mobilized and gave ALL 100 vaccines) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant Medications were  provided by Reporter
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Pain, Pyrexia
Clinical narrative: no energy at all; aches and pains; fever over 105 for like 5 days; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (no energy at all), PAIN (aches and pains) and PYREXIA (fever over 105 for like 5 days) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (no energy at all), PAIN (aches and pains) and PYREXIA (fever over 105 for like 5 days). At the time of the report, ASTHENIA (no energy at all), PAIN (aches and pains) and PYREXIA (fever over 105 for like 5 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant Medications were  provided by Reporter No treatment  Medications were  provided by Reporter   Reporter did not allow further contact
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Ultrasound scan
Clinical narrative: Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant) in a 30-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 028L20A) for COVID-19 vaccination.     The patient's past medical history included Stomach flu. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) and POLYCARBOPHIL CALCIUM (FIBER) for an unknown indication.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 24-Dec-2020 and the estimated date of delivery was 02-Oct-2021. On 19-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  third week of the pregnancy.  On 18-Feb-2021, EXPOSURE DURING PREGNANCY (Pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Ultrasound scan: unknown (Positive) Positive pregnancy..         Treatment information was not provided.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dyspnoea
Clinical narrative: Mild cough; Shortness of breath; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (Shortness of breath) and COUGH (Mild cough) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 072M204) for COVID-19 vaccination.     Concomitant products included OMEPRAZOLE and CARISOPRODOL (SOMA [CARISOPRODOL]) for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced DYSPNOEA (Shortness of breath). On 06-Feb-2021, the patient experienced COUGH (Mild cough). At the time of the report, DYSPNOEA (Shortness of breath) and COUGH (Mild cough) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment includes inhaler fovent
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Feeling abnormal, Nausea, Vaccination site pain
Clinical narrative: swelling at injection site; pain at injection site; fatigue; Nauseous; dizzy; mental fog; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), FEELING ABNORMAL (mental fog), VACCINATION SITE SWELLING (swelling at injection site), VACCINATION SITE PAIN (pain at injection site) and FATIGUE (fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced DIZZINESS (Dizzy), FEELING ABNORMAL (mental fog) and NAUSEA (Nauseous). On an unknown date, the patient experienced VACCINATION SITE SWELLING (swelling at injection site), VACCINATION SITE PAIN (pain at injection site) and FATIGUE (fatigue). At the time of the report, DIZZINESS (Dizzy), FEELING ABNORMAL (mental fog), VACCINATION SITE SWELLING (swelling at injection site), VACCINATION SITE PAIN (pain at injection site), FATIGUE (fatigue) and NAUSEA (Nauseous) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: Reporter Contact information updated
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: swelling at injection site; pain at injection site; fatigue; Nauseous; dizzy; mental fog; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), FEELING ABNORMAL (mental fog), VACCINATION SITE SWELLING (swelling at injection site), VACCINATION SITE PAIN (pain at injection site) and FATIGUE (fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced DIZZINESS (Dizzy), FEELING ABNORMAL (mental fog) and NAUSEA (Nauseous). On an unknown date, the patient experienced VACCINATION SITE SWELLING (swelling at injection site), VACCINATION SITE PAIN (pain at injection site) and FATIGUE (fatigue). At the time of the report, DIZZINESS (Dizzy), FEELING ABNORMAL (mental fog), VACCINATION SITE SWELLING (swelling at injection site), VACCINATION SITE PAIN (pain at injection site), FATIGUE (fatigue) and NAUSEA (Nauseous) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: Reporter Contact information updated
Sex: F
Vaccine: COVID19
Symptoms: Induration, Macule, Product administered at inappropriate site, Swelling
Clinical narrative: Swelling; Hardness; Pink Dots; Moderna Vaccine Administered in right Thigh; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swelling), INDURATION (Hardness), MACULE (Pink Dots) and PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Moderna Vaccine Administered in right Thigh) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no reported medical history).   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 03-Feb-2021, the patient experienced PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Moderna Vaccine Administered in right Thigh). On 11-Feb-2021, the patient experienced SWELLING (Swelling), INDURATION (Hardness) and MACULE (Pink Dots). On 03-Feb-2021, PRODUCT ADMINISTERED AT INAPPROPRIATE SITE (Moderna Vaccine Administered in right Thigh) had resolved. On 15-Feb-2021, SWELLING (Swelling), INDURATION (Hardness) and MACULE (Pink Dots) had resolved. Not Provided          Concomitant information not provided. Treatment included  "Cortizone-10" - Self medicating to try to alleviate symptoms. "Cold Compress" - Self medicating to try to alleviate the symptoms   This case was linked to MOD-2021-037401 (Patient Link).
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Fatigue, Inappropriate affect, Lethargy
Clinical narrative: Felt weak; Felt kind of funny; Lethargic; Dizzy where she almost had an incidence of falling while getting up; Chronic fatigue; Tenderness under her arm in the lymph node; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), ASTHENIA (Felt weak), INAPPROPRIATE AFFECT (Felt kind of funny), LETHARGY (Lethargic) and DIZZINESS (Dizzy where she almost had an incidence of falling while getting up) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced DIZZINESS (Dizziness), FATIGUE (Chronic fatigue) and LYMPH NODE PAIN (Tenderness under her arm in the lymph node). On 06-Mar-2021, the patient experienced ASTHENIA (Felt weak), INAPPROPRIATE AFFECT (Felt kind of funny), LETHARGY (Lethargic) and DIZZINESS (Dizzy where she almost had an incidence of falling while getting up). The patient was treated with PARACETAMOL (TYLENOL 8 HOUR) at an unspecified dose and frequency. On 06-Mar-2021, DIZZINESS (Dizzy where she almost had an incidence of falling while getting up) outcome was unknown. At the time of the report, DIZZINESS (Dizziness), ASTHENIA (Felt weak), INAPPROPRIATE AFFECT (Felt kind of funny), LETHARGY (Lethargic), FATIGUE (Chronic fatigue) and LYMPH NODE PAIN (Tenderness under her arm in the lymph node) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain
Clinical narrative: Felt weak; Felt kind of funny; Lethargic; Dizzy where she almost had an incidence of falling while getting up; Chronic fatigue; Tenderness under her arm in the lymph node; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), ASTHENIA (Felt weak), INAPPROPRIATE AFFECT (Felt kind of funny), LETHARGY (Lethargic) and DIZZINESS (Dizzy where she almost had an incidence of falling while getting up) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced DIZZINESS (Dizziness), FATIGUE (Chronic fatigue) and LYMPH NODE PAIN (Tenderness under her arm in the lymph node). On 06-Mar-2021, the patient experienced ASTHENIA (Felt weak), INAPPROPRIATE AFFECT (Felt kind of funny), LETHARGY (Lethargic) and DIZZINESS (Dizzy where she almost had an incidence of falling while getting up). The patient was treated with PARACETAMOL (TYLENOL 8 HOUR) at an unspecified dose and frequency. On 06-Mar-2021, DIZZINESS (Dizzy where she almost had an incidence of falling while getting up) outcome was unknown. At the time of the report, DIZZINESS (Dizziness), ASTHENIA (Felt weak), INAPPROPRIATE AFFECT (Felt kind of funny), LETHARGY (Lethargic), FATIGUE (Chronic fatigue) and LYMPH NODE PAIN (Tenderness under her arm in the lymph node) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Feeling hot, Mass, Pruritus
Clinical narrative: rash has ballooned to take up most of arm; kind of itchy; hot; hard; very red; rash; very tired; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (rash has ballooned to take up most of arm), PRURITUS (kind of itchy), FEELING HOT (hot), MASS (hard) and ERYTHEMA (very red) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced FATIGUE (very tired). On 05-Mar-2021, the patient experienced SWELLING (rash has ballooned to take up most of arm), PRURITUS (kind of itchy), FEELING HOT (hot), MASS (hard), ERYTHEMA (very red) and RASH (rash). On 25-Feb-2021, FATIGUE (very tired) had resolved. At the time of the report, SWELLING (rash has ballooned to take up most of arm), PRURITUS (kind of itchy), FEELING HOT (hot), MASS (hard), ERYTHEMA (very red) and RASH (rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant Medications were  provided by Reporter No Treatment Medications were  provided by Reporter
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Swelling
Clinical narrative: rash has ballooned to take up most of arm; kind of itchy; hot; hard; very red; rash; very tired; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (rash has ballooned to take up most of arm), PRURITUS (kind of itchy), FEELING HOT (hot), MASS (hard) and ERYTHEMA (very red) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced FATIGUE (very tired). On 05-Mar-2021, the patient experienced SWELLING (rash has ballooned to take up most of arm), PRURITUS (kind of itchy), FEELING HOT (hot), MASS (hard), ERYTHEMA (very red) and RASH (rash). On 25-Feb-2021, FATIGUE (very tired) had resolved. At the time of the report, SWELLING (rash has ballooned to take up most of arm), PRURITUS (kind of itchy), FEELING HOT (hot), MASS (hard), ERYTHEMA (very red) and RASH (rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant Medications were  provided by Reporter No Treatment Medications were  provided by Reporter